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ABSTRACT
Six fungi strains (M. anisopliae 3935, 4516, 4819, PL57, PL43 and M. flavoviride CG291) were studied regarding
their ability to produce an anticancer indolizidine alkaloid. The culture process was carried out in Shaken flask
at 26ºC and 200 rpm using three different culture medium containing oat meal extract supplemented with
glucose and DL-lysine or Czapek culture medium. The mycelial extracts produced by Metarhizium spp.
cultures were directly submitted to electrospray ionization mass spectrometry (ESI-MS) analysis and the
highest alkaloid concentration (approximately, 6 mg.L-1) was reached when M. anisopliae 3935 was tested.
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INTRODUCTION
Nowadays, the cancer is the second largest death cause
after the cardiovascular diseases. However, according to recent
estimates of the World Health Organization (WHO) up to 2015
this disease can be the first death cause in the world since that
more than 10 million people in the world develop the cancer
every year and approximately 6 million die because of this
disease. In this context, is well-known the need to develop new
products and processes to complement the used procedures in
this disease treatment.
In the present study, several Metarhizium ssp. strains were
evaluated with respect to its ability to produce an anticancer
alkaloid commonly known as swainsonine because it was
firstly isolated from the Australian legume Swainsona
canescens (Fig. 1).
Swainsonine is a polyhydroxylated indolizidine alkaloid
that has been isolated from plants (1-3) and produced, as a
secondary metabolite, by cultures of Rhizoctonia
leguminocola (4), M. anisopliae (5-7) and more recently by
fungal endophytes of locoweed (8). On the other hand, this
alkaloid and its analogues have been chemically synthesized
(9) which is very expensive due to the difficulties created by
their four chiral centers resulting in more than twenty reaction
steps and in racemic mixtures.
A number of the polyhydroxylated alkaloids have been
reported with anticancer activity (10), however swainsonine
has attracted significant attention in recent years because of its
antimetastatic, antiproliferative and immunomodulatory activity,
finding applications in the therapeutic treatment of the cancer
and AIDS (10-14). In despite of, extraction by plant and chemical
synthesis, the swainsonine production by fungal cultures has
received a little attention. Consequently, in this work we
Figure 1. Polyhydroxylated indolizine alkaloid ((1S, 2R, 8R,
8aR)-1,2,8-trihydroxyocta-hydroindolizidine).
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investigated the preliminary swainsonine production in a
laboratory scale in Erlenmeyer shaken flask by six strains of




M. anisopliae 3935, 4516 and 4819 were obtained from
Tropical Research Foundation “André Tosello” culture
collection, Campinas, Brazil. M. anisopliae PL57, PL43 and M.
flavoviride CG291 were kindly provided by Doctor João Lúcio
de Azevedo from College of Agriculture “Luiz de Queiroz”
(ESALQ/USP), Brazil. Stock cultures were maintained on oatmeal
agar at 4ºC. Swainsonine from Rhizoctonia leguminocola was
purchased from Sigma-Aldrich, USA and dissolved in water to
yield a standard solution of 0.1% w/v. The analytical grade
water was purified in a Milli-Q system (Millipore, Bedford, USA).
All chemical reagents and culture media used in this work were
purchased from Merck and Sigma-Aldrich.
Culture media preparation
Three different culture media were employed: M1- medium
based on oatmeal extract 2% w/v was prepared by cooking
oatmeal in distilled water for approximately 10 minutes followed
by filtration. After, this solution was supplemented with 10
g.L-1 D-glucose and 0.1 g.L-1 DL-lysine solution. M2 - similar to
M1 medium based on oatmeal extract 2% w/v, supplemented
with 10 g.L-1 D-glucose solution and 1.8 g.L-1 DL-lysine solution.
M3 - Czapek medium with the addition of 1.8 g.L-1 of DL-lysine.
All media were sterilised at 121ºC, 15 psi for 15 min.
Fermentation
Spore suspensions were prepared from previously
sporulated cultures on oatmeal agar slopes by vigorous
vortexing in sterile water. Inoculums, of approximately 107
spores.mL-1 counted in a Neubauer camera, were aseptically
added to each Erlenmeyer flask containing sterile medium. Thus,
fermentations were carried out in shaken flasks (250 mL) at 26ºC
and 200 rpm for 10 days.
Biomass determination
The biomass was determined by dry mass analysis. Fermented
medium samples were filtered through pre-weighed filter paper
(Whatman No.1) and the harvested biomass was washed twice
with distilled water and then dried until constant weight at 65ºC
and 8 kPa in a vacuum oven GST-920 model (SUPRILAB, Brazil).
Glucose assay
The glucose concentration was measured at 500 nm, using a
spectrophotometer model 4800 (Hach Company, USA),
according to the glucose oxidase method using a quantitative
Glucose Enzyme Color Reagent kit from Bio Diagnóstica
(Curitiba, PR, Brazil).
Identification and alkaloid concentration quantification
The alkaloid determination was carried out by Electrospray
ionization mass espectrometric (ESI-MS) analysis in a positive
mode using a Q-TOF mass spectrometer (Micromass,
Manchester, UK). The general conditions were established
according to Moller et al. (16): source temperature at 80ºC,
capillary voltage of 3 kV and cone voltage of 40 V. For detection
and alkaloid quantification a standard curve was prepared
adding 0.5 µL of formic acid and methanol solution (1:1 v/v) to
the standard swainsonine solution (500 µL) to yield 0.1% as the
final concentration whose solution was conveniently diluted.
The fermented medium samples were prepared by similar form
and the ESI(+)-MS analysis was carried out by direct infusion
with a flow rate of 10 µLmin-1 using a syringe pump (Harvard
apparatus). Mass spectra was acquired and accumulated over
60 s and scanned over 50 to 800 m/z range. The ion of interest
was judged by visual inspection and compared with the standard
and then ESI-MS/MS was performed to acquire its mass
spectrum and verify the alcaloide production.
RESULTS AND DISCUSSION
The fermented media at the end process were filtrated at
vacuum, centrifuged at 2000´g in an EPPENDORF refrigerated
centrifuge (model 5804R) and the supernatants were analyzed
for determination produced alkaloid by ESI-MS. Previously, the
standard swainsonine sample was examined by ESI(+)-MS
yielded a intense protonated molecular ion ([M+H]+) as the
most abundant ionization product, as is shown in the Fig. 2A,
at m/z 174 which is characteristic of this molecule. After, direct
infusion of fermented culture medium under ESI(+)-MS yielded
spectra with a number of ions between 50 to 800 m/z scanned
range shown as illustrative way for fermented culture by 3935
strain in the Fig. 2B and 2C. Nevertheless, similarly to the
standard analysis the mass spectrum shows an protonated
molecular ion at m/z 174, suggesting the tryhydroxylated
alkaloid swainsonine presence, although numerous other peak
occur in the ESI-MS analysis, possibly corresponding to other
metabolites, residual culture medium and several extracellular
compounds excreted by cell and consequently present in the
sample analysis. Then, ESI-MS/MS was performed by mass
selecting of ion at m/z 174 (Fig. 2B and 2C) and its spectra,
correspondents to the are shown, for the standard and
fermented culture by 3935 strain, in Fig. 3A to 3C. The resulting
MS/MS product ion spectra exhibited successive losses of 18
a.m.u, suggesting losses of hydroxyl groups as water
corresponding to the ions m/z 156, 138 and 120, respectively,
which allowed to confirm the swainsonine alkaloid production.
Although a large number of compounds are present in fermented
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culture medium, fluctuation in the relative intensities of the signal
ions was not found by direct infusion of the samples. In addition,
with this technique derivatization is avoided and the extended
analysis time used in gas chromatographic e.g. is drastically
reduced.
ESI(+)-MS was performed by direct infusions to determine
the produced alkaloid, according to the standard curve attained
for several concentration values of standard alkaloid. In this
context, the produced alkaloid for all experiment are shown in
the Fig. 4 together with the formed biomass, concentration
glucose and pH. As observed, four strains produced the
indolizidine alkaloid, M. anisopliae 3935, PL57 e PL43 and M.
flavoviride CG291. However, the highest alkaloid concentration,
approximately, 6.0 mg.L-1 was attained when oatmeal extract
supplemented with 1.8 g.L-1 DL-lysine (M2 medium) was used
in the M. anisopliae 3935 culture. This culture medium was also
the most favorable for the alkaloid production by PL57 and
PL43 strains. When lysine and glucose were not used or when
a low lysine concentration was used in the culture medium,
extracellular alkaloid production was not detected. Therefore,
we verified that lysine was a precursor for alkaloid production.
On the other hand, the alkaloid biosynthetic pathway, which
proceeds by lysine catabolism via Saccharopine, has been
investigate by Harris (3) and Sim and Perry (15), but has not
been completely explained.
A morphological analysis of the fermented culture medium
showed a combination of both hyphal and pelleted growth.
However, during the fermentation the biomass migrated and
accumulated at the surface of the cultures. Probably, the
extracellular alkaloid concentration was influenced by this fact.
However, intracellular amounts of this alkaloid were not verified.
M. anisopliae 3935 presented a satisfactory growth in all
culture media after 10 days of fermentation, not showing a
significant variation in the relative biomass value (Fig. 4). On
the other hand, the PL43 strain presented more higher growth
on Czapek medium, but the alkaloid concentration was one of
the smallest (0.9 mg.L-1), i.e., the alkaloid production was
inversely proportional to the fungus growth. The same results
were observed for the PL57 strain, suggesting that the conditions
which favor the cell growth were different from those that
Figure 2. Electro-Spray Ionisation Mass Spectra obtained in a positive mode (ESI(+)-MS) of swainsonine standard obtained from
Sigma (A), alkaloid obtained by Metarhizium anisopliae 3935 in oatmeal culture fermented medium (B) and in a Czapek-Dox culture
fermented medium (C).
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CONCLUSION
The highest indolizidine alkaloid concentration was
reached when oatmeal extract supplemented with 1.8 g.L-1
DL-lysine (M2 medium) was fermented by M. anisopliae 3539
and further studies to understand the alkaloid biosynthesis
in order to optimize the fermentation process are in progress.
The ESI-MS/MS provides a direct, simple, rapid and sensitive
method for the formed alkaloid analysis of direct infusion of
fermented culture medium by cultures of Metarhizium spp.
strain.
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Figure 3. ESI(+)-MS/MS of swainsonine standard obtained from Sigma (A), swainsonine obtained by Metarhizium anisopliae
3935 in oatmeal culture fermented medium (B) and in a Czapek-Dox culture fermented medium (C).
influenced the alkaloid production, e.g., low pH values showed
a positive effect on the alkaloid production (Fig. 4).
Figure 4. Obtained results for all fermented cultures in
Erlenmeyer flask at 26ºC and 200 rpm, during 10 days, using the
M1, M2 e M3 culture media.   - Alkaloid (mg.L-1);  - Biomass
(g.L-1);  Glucose (g.L-1);  pH.
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RESUMO
Seleção de linhagens de Metarhizium spp. para a
produção de alcalóide indolizidínico anticancerígeno e
sua rápida detecção por MS análise
O presente trabalho teve como objetivo avaliar diferentes
cepas dos fungos M. anisopliae e M. flavoviride ao respeito
da sua capacidade de produzir um alcalóide anticancerígeno,
por fermentação em frascos erlenmeyers usando três meios de
cultura distintos. De seis cepas testadas, quatro foram capazes
de produzir o composto de interesse, M. anisopliae 3935, PL57
e PL43 e M. flavoviride CG291, sendo que a maior concentração
de alcalóide (aproximadamente, 6 mg.L-1) foi produzida pelo M.
anisopliae 3935, contendo um meio constituído de extrato de
farinha de aveia, glicose e DL-lisina a 26ºC e 200 rpm.
Palavras-chave: M. anisopliae, M. flavoviride, metabolito se-
cundário, alcalóide anticancerígeno
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